Related references
Note: Only part of the references are listed.High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study
N. Rabbani et al.
DIABETOLOGIA (2009)
Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications
Elena Beltramo et al.
ACTA DIABETOLOGICA (2008)
Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes
X. Du et al.
DIABETOLOGIA (2008)
The Role of Inflammatory Cytokines in Diabetes and Its Complications
George L. King
JOURNAL OF PERIODONTOLOGY (2008)
Leptin resistance - A possible interface of inflammation and metabolism in obesity-related cardiovascular disease
Seth S. Martin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease
P. J. Thornalley et al.
DIABETOLOGIA (2007)
Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes
Alin Stirban et al.
DIABETES CARE (2006)
Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt/FoxO signaling
Valentina Marchetti et al.
DIABETES (2006)
The Potential Role of Thiamine (Vitamin B-1) in Diabetic Complications
Paul J. Thornalley
CURRENT DIABETES REVIEWS (2005)
High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats
R Babaei-Jadidi et al.
DIABETOLOGIA (2004)
Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine
R Babaei-Jadidi et al.
DIABETES (2003)
Share Paper
